Exercise / IGFBP3 Cancer Research Results

Ex, Exercise: Click to Expand ⟱
Features: Therapy
Regular physical activity has been shown to influence cancer risk, progression, and survivorship. While exercise is not a cure for cancer, extensive research indicates that it can help reduce the risk of developing certain types of cancer and improve outcomes and quality of life for those diagnosed.

-Lowering the levels of hormones levels.
-Preventing high blood levels of insulin.
-Regular physical activity leads to decreased levels of inflammatory markers (such as C-reactive protein and interleukin-6).
-Improving immune system function (enhancing the circulation of immune cells, including natural killer cells, T lymphocytes, and macrophages)
-Reducing the time it takes for food to travel through the digestive system.
-Helping to prevent obesity, which is a risk factor for many cancers.
-Exercise promotes the upregulation of antioxidant defenses.
Exercise simultaneously modulates multiple core cancer drivers:
  ↓ Insulin / IGF-1 signaling
  ↓ Chronic inflammation (IL-6, TNF-α baseline)
  ↑ Immune surveillance (NK cells, CD8⁺ T cells)
  ↑ Mitochondrial function and mitophagy
  ↓ Estrogen and androgen bioavailability
  ↑ Circadian stability
  ↓ Visceral adiposity (key endocrine organ)
No supplement or single molecule does this breadth of work.

Exercise, fasting, and diet work by changing the environment tumors depend on — not by poisoning the tumor.


Age-stratified interpretation 
1. Younger / metabolically healthy adults
-Baseline IGF-1: normal–high
-Exercise effect:
  -Systemic IGF-1 ↔ or slight ↓
  -IGF-1 signaling efficiency ↑ (better receptor sensitivity)
-Net effect:
  -Less chronic growth drive
  -Better metabolic control
➡ This is where IGF-1 ↓ papers usually come from.

2. Older adults (≈50–60+ years)
-Baseline IGF-1: low
-Exercise effect:
  -IGF-1 ↑ (restoration toward youthful range)
  -Improved GH → IGF-1 axis responsiveness
-Net effect:
  -Muscle, bone, immune maintenance
  -Reduced frailty and inflammation
➡ This is where IGF-1 ↑ papers come from.

3. Cancer relevance (critical distinction)
-Even when circulating IGF-1 increases in older exercisers:
-Tumor IGF-1 signaling still goes DOWN, because:
  -Insulin sensitivity improves
  -IGFBP balance shifts
  -Inflammation drops
  -mTOR tone is suppressed
  -AMPK tone is elevated
So:
-Host IGF-1 ↑ ≠ tumor IGF-1 signaling ↑
Exercise — Cancer vs Normal Cell Effects
Rank Pathway / Axis Cancer Cells Normal Cells Label Primary Interpretation Notes
1 Insulin / IGF-1 signaling ↓ IGF-1 signaling (tumor context) ↑ or ↓ IGF-1 (age- and baseline-dependent normalization) Driver Growth-signal reprogramming Exercise normalizes IGF-1 toward age-appropriate levels while reducing tumor-promoting signaling
2 AMPK → mTOR nutrient sensing ↑ AMPK; ↓ mTOR (growth restraint) ↑ AMPK; ↓ mTOR (metabolic optimization) Driver Energy-sensing reprogramming Repeated AMPK activation enforces catabolic signaling incompatible with tumor anabolism
3 Immune surveillance (NK cells, T cells) ↑ immune-mediated tumor pressure ↑ immune competence Driver Enhanced antitumor immunity Exercise mobilizes NK cells and improves immune trafficking into tumors
4 Mitochondrial metabolism / metabolic flexibility ↓ metabolic advantage ↑ mitochondrial capacity and flexibility Secondary Energy efficiency divergence Normal cells adapt metabolically; cancer cells lose relative advantage
5 Reactive oxygen species (ROS) ↑ ROS (secondary, transient) ↑ transient ROS → adaptive signaling Secondary Hormetic redox signaling Exercise induces transient ROS that act as signals rather than toxins
6 Glutathione (GSH) and antioxidant capacity ↔ or insufficient upregulation ↑ GSH and antioxidant enzymes Adaptive Redox resilience in normal tissue Normal cells adaptively increase antioxidant defenses; tumors adapt poorly
7 NRF2 antioxidant response ↔ modest activation ↑ NRF2 (adaptive) Adaptive Stress adaptation NRF2 supports recovery and resilience rather than cytotoxicity
8 Inflammatory signaling (NF-κB / cytokines) ↓ pro-tumor inflammation ↓ chronic inflammation Secondary Anti-inflammatory milieu Exercise reduces chronic low-grade inflammation that supports tumor progression
9 Cell cycle / proliferation ↓ proliferation (indirect) ↔ normal turnover Phenotypic Growth restraint Proliferation effects arise from upstream hormonal and metabolic changes


Exercise — Alzheimer’s Disease & Cognitive Decline
Rank Pathway / Axis Direction Label Primary Interpretation Key Cognitive / AD Relevance Notes
1 BDNF / TrkB neurotrophic signaling ↑ BDNF Driver Synaptic plasticity and neuronal survival Improves learning, memory consolidation, and hippocampal resilience BDNF induction is the single most robust and reproducible neurocognitive effect of exercise
2 Neurogenesis (hippocampal dentate gyrus) ↑ neurogenesis Driver Structural cognitive reserve Supports memory formation and delays cognitive decline Adult hippocampal neurogenesis is exercise-responsive and BDNF-dependent
3 Cerebral blood flow / angiogenesis (VEGF) ↑ perfusion Driver Improved nutrient and oxygen delivery Enhances executive function and processing speed Vascular health strongly predicts AD progression
4 Mitochondrial biogenesis (PGC-1α) ↑ mitochondrial capacity Driver Energy resilience in neurons Preserves synaptic function and neuronal firing reliability Mitochondrial dysfunction is an early AD feature
5 Neuroinflammation (microglia, cytokines) ↓ chronic inflammation Driver Microglial normalization Reduces neurotoxic inflammatory signaling linked to cognitive decline Exercise shifts microglia toward a neuroprotective phenotype
6 Insulin signaling / brain glucose utilization ↑ insulin sensitivity Secondary Improved neuronal fuel utilization Supports memory and executive function “Type 3 diabetes” concept in AD makes this pathway central
7 Amyloid-β production & clearance ↓ Aβ burden (modest) Secondary Reduced proteotoxic stress Slows pathological cascade rather than reversing plaques Exercise improves clearance more than production suppression
8 Tau phosphorylation / aggregation ↓ tau pathology (indirect) Secondary Axonal stability preservation Supports memory retention and neuronal transport Effect mediated via inflammation and insulin signaling
9 Oxidative stress / ROS ↓ chronic ROS Adaptive Redox stabilization Protects synapses and mitochondria Transient exercise ROS induces long-term antioxidant adaptation
10 Cognitive performance (memory, executive function) ↑ performance Phenotypic Functional outcome Improved memory, attention, processing speed Emergent result of upstream neurotrophic, vascular, and metabolic effects


IGFBP3, Insulin-Like Growth Factor Binding Protein-3: Click to Expand ⟱
Source:
Type:
One of the six members of the IGFBP family, is a key protein in the IGF pathway. IGFBP-3 is the most abundant in the blood circulation. Prostate specific antigen (PSA), which is frequently used as a clinical tumor marker for prostate cancer, cleaves IGFBP-3.

Tumor Types:
IGFBP-3 expression can vary significantly across different cancer types. It is often downregulated in several malignancies, including breast cancer, prostate cancer, colorectal cancer, and lung cancer.
In some cases, low levels of IGFBP-3 are associated with tumor progression and poor clinical outcomes.

Tumor Suppressor Functions:
IGFBP-3 is often considered a tumor suppressor due to its ability to inhibit the actions of IGF-1 and IGF-2, which promote cell proliferation and survival. By binding to IGFs, IGFBP-3 can prevent their interaction with IGF receptors, thereby inhibiting their mitogenic effects.

High levels of IGFBP-3 are generally associated with a favorable prognosis in several cancers. For example, elevated IGFBP-3 levels in breast cancer and prostate cancer have been linked to better survival outcomes.
Conversely, low levels of IGFBP-3 are often associated with aggressive tumor behavior and poorer prognosis.
Scientific Papers found: Click to Expand⟱
5063- Ex,    A randomized controlled trial on the efficacy of supervised exercise training in reducing IGF-1 levels in breast cancer survivors of the Movis’ cohort
- Trial, BC, NA
IGF-1↓, IGFBP3↓,
5234- Ex,    Intense Walking Exercise Affects Serum IGF-1 and IGFBP3
- Trial, Nor, NA
*IGF-1↓, *IGFBP3↓,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Proliferation, Differentiation & Cell State ⓘ

IGF-1↓, 1,   IGFBP3↓, 1,  
Total Targets: 2

Pathway results for Effect on Normal Cells:


Proliferation, Differentiation & Cell State ⓘ

IGF-1↓, 1,   IGFBP3↓, 1,  
Total Targets: 2

Scientific Paper Hit Count for: IGFBP3, Insulin-Like Growth Factor Binding Protein-3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:171  Target#:417  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page